For the quarter ended June 2025, Cognizant (CTSH) reported revenue of $5.25 billion, up 8.1% over the same period last year. EPS came in at $1.31, compared to $1.17 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $5.19 billion, representing a surprise of +1.01%. The company delivered an EPS surprise of +3.97%, with the consensus EPS estimate being $1.26.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Cognizant performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenues- Health Sciences: $1.55 billion compared to the $1.61 billion average estimate based on two analysts. The reported number represents a change of +6.2% year over year.
- Revenues- Communications, Media and Technology: $841 million versus the two-analyst average estimate of $826.36 million. The reported number represents a year-over-year change of +3.1%.
- Revenues- Products and Resources: $1.31 billion versus $1.25 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +16% change.
- Revenues- Financial services: $1.55 billion compared to the $1.52 billion average estimate based on two analysts. The reported number represents a change of +6.9% year over year.
View all Key Company Metrics for Cognizant here>>>
Shares of Cognizant have returned -6.9% over the past month versus the Zacks S&P 500 composite's +3.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Cognizant Technology Solutions Corporation (CTSH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
